Dr. Lal Path Labs Ltd. (LALPATHLAB) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.134x

Based on the latest financial reports, Dr. Lal Path Labs Ltd. (LALPATHLAB) has a cash flow conversion efficiency ratio of 0.134x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.24 Billion ≈ $35.04 Million USD) by net assets (Rs24.22 Billion ≈ $261.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check LALPATHLAB strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Dr. Lal Path Labs Ltd. - Cash Flow Conversion Efficiency Trend (2011–2026)

This chart illustrates how Dr. Lal Path Labs Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. See what is Dr. Lal Path Labs Ltd.'s book value for net asset value and shareholders' equity analysis.

Dr. Lal Path Labs Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dr. Lal Path Labs Ltd. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CorVel Corp NASDAQ:CRVL	0.123x
Dave Inc NASDAQ:DAVE	0.403x
Hycroft Mining Holding Corporation NASDAQ:HYMC	-0.140x
Roshow Technology Co Ltd SHE:002617	-0.024x
Dongfang Electronics Co Ltd SHE:000682	0.033x
Bank of Queensland Ltd AU:BOQ	0.082x
Servyou Software Group Co Ltd SHG:603171	0.030x
Lotte Shopping KO:023530	0.036x

Annual Cash Flow Conversion Efficiency for Dr. Lal Path Labs Ltd. (2011–2026)

The table below shows the annual cash flow conversion efficiency of Dr. Lal Path Labs Ltd. from 2011 to 2026. For the full company profile with market capitalisation and key ratios, see Dr. Lal Path Labs Ltd. stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs25.41 Billion ≈ $274.83 Million	Rs7.02 Billion ≈ $75.92 Million	0.276x	+7.16%
2025-03-31	Rs22.07 Billion ≈ $238.62 Million	Rs5.69 Billion ≈ $61.51 Million	0.258x	-9.21%
2024-03-31	Rs18.85 Billion ≈ $203.89 Million	Rs5.35 Billion ≈ $57.89 Million	0.284x	+5.82%
2023-03-31	Rs17.00 Billion ≈ $183.79 Million	Rs4.56 Billion ≈ $49.31 Million	0.268x	-7.28%
2022-03-31	Rs15.44 Billion ≈ $166.93 Million	Rs4.47 Billion ≈ $48.31 Million	0.289x	-7.25%
2021-03-31	Rs12.76 Billion ≈ $138.00 Million	Rs3.98 Billion ≈ $43.06 Million	0.312x	+15.85%
2020-03-31	Rs10.54 Billion ≈ $113.99 Million	Rs2.84 Billion ≈ $30.70 Million	0.269x	+17.20%
2019-03-31	Rs9.51 Billion ≈ $102.84 Million	Rs2.19 Billion ≈ $23.63 Million	0.230x	-7.30%
2018-03-31	Rs7.95 Billion ≈ $85.97 Million	Rs1.97 Billion ≈ $21.31 Million	0.248x	-4.36%
2017-03-31	Rs6.62 Billion ≈ $71.61 Million	Rs1.72 Billion ≈ $18.56 Million	0.259x	-10.07%
2016-03-31	Rs5.10 Billion ≈ $55.10 Million	Rs1.47 Billion ≈ $15.88 Million	0.288x	+1.14%
2015-03-31	Rs3.43 Billion ≈ $37.14 Million	Rs978.50 Million ≈ $10.58 Million	0.285x	-32.12%
2014-03-31	Rs2.33 Billion ≈ $25.23 Million	Rs979.58 Million ≈ $10.59 Million	0.420x	-22.03%
2013-03-31	Rs1.64 Billion ≈ $17.70 Million	Rs881.31 Million ≈ $9.53 Million	0.538x	-7.47%
2012-03-31	Rs1.17 Billion ≈ $12.66 Million	Rs681.28 Million ≈ $7.37 Million	0.582x	+30.20%
2011-03-31	Rs934.94 Million ≈ $10.11 Million	Rs417.87 Million ≈ $4.52 Million	0.447x	--

About Dr. Lal Path Labs Ltd.

NSE:LALPATHLAB India Diagnostics & Research

Market Cap

$2.92 Billion

Rs270.04 Billion INR

Market Cap Rank

#5119 Global

#223 in India

Share Price

Rs1617.20

Change (1 day)

+0.82%

52-Week Range

Rs1307.60 - Rs3473.50

All Time High

Rs4119.53